3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Gastrointestinal
1
Conditions
Venous Thromboembolism
2
Venous Thrombosis
1
Thrombocytopenia
1
Pulmonary Embolism
1
Gastrointestinal Neoplasms
1
Interventions
apixaban
10
Rivaroxaban
5
Aspirin
4
Enoxaparin
3
abelacimab
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Dalteparin
2
ribociclib
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
edoxaban
1
abemaciclib
1
Rosuvastatin Calcium
1
N(4)-oleylcytosine arabinoside
1
Educational Status
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Dalteparin
×
1 year
×
Clear all
NCT05171075
2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3
Terminated
417 enrolled
NCT03045406
2025-06-24
CARAVAGGIO
Fadoi Foundation, Italy
Phase 3
Completed
1,170 enrolled
11 charts